← Back to directory

Tanja Stamm

Researcher Next ID · RN-040153

Researcher · Economics, Econometrics and Finance

Statistics Austria

Vienna, Austria

Accepting doctoral researchersFunding unknown
Works count
510
Citation count
24,915
H-index
67
i10-index
220

Research interests

Economics, Econometrics and Finance
Medicine
Rheumatoid Arthritis Research and Therapies
Spondyloarthritis Studies and Treatments
Autoimmune and Inflammatory Disorders Research
Health Systems, Economic Evaluations, Quality of Life
Osteoarthritis Treatment and Mechanisms

Publications

  • EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    Annals of the Rheumatic Diseases · 2023 · 10.1136/ard-2023-224416

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/ard-2022-223356

  • American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision

    Annals of the Rheumatic Diseases · 2022 · 10.1136/ard-2022-223413

  • 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

    Annals of the Rheumatic Diseases · 2022 · 10.1136/annrheumdis-2022-222341

  • Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Annals of the Rheumatic Diseases · 2022 · 10.1136/ard-2022-223357

  • Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

    Annals of the Rheumatic Diseases · 2022 · 10.1136/ard-2022-223365

  • 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    Annals of the Rheumatic Diseases · 2022 · 10.1136/annrheumdis-2021-222020

  • 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

    Annals of the Rheumatic Diseases · 2021 · 10.1136/annrheumdis-2021-220249

  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

    Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-217877

  • 2018 update of the EULAR recommendations for the management of hand osteoarthritis

    Annals of the Rheumatic Diseases · 2018 · https://doi.org/10.1136/annrheumdis-2018-213826

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211734

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2016-210715

  • Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

    Annals of the Rheumatic Diseases · 2015 · https://doi.org/10.1136/annrheumdis-2015-207526

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Annals of the Rheumatic Diseases · 2015 · https://doi.org/10.1136/annrheumdis-2015-207524

  • A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2014-205207

  • Individual interviews and focus groups in patients with rheumatoid arthritis: a comparison of two qualitative methods

    Quality of Life Research · 2011 · 10.1007/s11136-011-9943-2

  • Core Outcome Domains for Controlled Trials and Clinical Recordkeeping in Eczema: International Multiperspective Delphi Consensus Process

    Journal of Investigative Dermatology · 2010 · 10.1038/jid.2010.303

  • The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

    Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2009.122473

  • The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritis

    Annals of the Rheumatic Diseases · 2007 · 10.1136/ard.2007.077081

  • Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease

    Lara D. Veeken · 2006 · https://doi.org/10.1093/rheumatology/kel237

  • Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups

    Arthritis Research & Therapy · 2006 · 10.1186/ar1956

  • Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states

    Arthritis & Rheumatism · 2005 · 10.1002/art.21235

  • Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

    Arthritis Research & Therapy · 2005 · 10.1186/ar1740

  • Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: A randomized controlled trial

    Arthritis Care & Research · 2002 · 10.1002/art1.10246

  • Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.

    PubMed · 2002

Current projects

    No projects listed.